Benztropine Mesylate

CAS 132-17-2 8 current records 1 historicalSmall Molecule

Who holds supplier records for Benztropine Mesylate? 8 organisations hold a current record for Benztropine Mesylate: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5), South Africa (1) and United States (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Benztropine Mesylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/benztropine-mesylate

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Benztropine Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India5South Africa1United States1Country not recorded for 1
Need Benztropine Mesylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Benztropine Mesylate are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Benztropine mesylate is an anticholinergic agent used to reduce extrapyramidal side effects associated with neuroleptic treatments and in the management of Parkinson's disease. It works by blocking acetylcholine receptors, hence balancing neurotransmitters to alleviate symptoms.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anticholinergic; Antihistamine
Mechanism of action
Cholinergic Antagonists; Histamine Receptor Antagonists

Therapeutic areas

NeurologyMovement Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Benztropine Mesylate?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Benztropine Mesylate: ARCH PHARMALABS LTD (India), Dr. Reddy's Laboratories Ltd. (India), ESCIENTIA ADVANCED SCIENCES PRIVATE LTD (India), Fine Chemicals Corporation (PTY) Ltd. (South Africa), HARMAN FINOCHEM LTD (India), KALINTIS HEALTHCARE PVT LTD (India), NAVINTA LLC (United States) and SIEGFRIED GRAFTON INC. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Benztropine Mesylate Drug Master Files are active?

ARCH PHARMALABS LTD (DMF 23719), Dr. Reddy's Laboratories Ltd. (DMF 7033), ESCIENTIA ADVANCED SCIENCES PRIVATE LTD (DMF 33480), Fine Chemicals Corporation (PTY) Ltd. (DMF 6914), HARMAN FINOCHEM LTD (DMF 33126), KALINTIS HEALTHCARE PVT LTD (DMF 34964), NAVINTA LLC (DMF 32136) and SIEGFRIED GRAFTON INC (DMF 28840). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Benztropine Mesylate records mean?

1 organisation has only inactive Type II DMFs for Benztropine Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Benztropine Mesylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Benztropine Mesylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.